Business Case Studies, Growth Strategies Case Study, Arcleor : Roche in China

print page
Tell A Friend

Case Categories

Growth Strategies Case Study

Case Title:

Roche in China in 2006

Publication Year : 2006

Authors: Ruchi Mankad, Dr. A.V Vedpuriswar

Industry: Health Care


Case Code: GRS0095A

Teaching Note: Not Available

Structured Assignment: Not Available

Buy This Case Study


In 2006, F. Hoffmann-La Roche & Co. (Roche) was one of the world’s leading research-intensive healthcare groups and its core businesses were pharmaceuticals and diagnostics. Roche employed about 65,000 people in 150 countries. Roche entered China in 1926 and had established its subsidiary in Shanghai. But for almost six decades, it did not have significant operations and presence and returned to the Chinese market in 1988. Roche had largely made its presence felt in China through joint ventures and it is only recently that it has opened a research centre in China. In 2004, Roche opened its new R&D center in Shanghai, China, which was part of Roche’s global R&D operations and which worked in collaboration with its other global centers. This is indicative of the growing importance of China for Roche and the pharmaceutical industry of the world.

The case traces the entry, re-entry, growth and ambitions of Roche in China. The case analyses the pharmaceutical industry in China and attempts at identifying the potential and challenges the country presents for Roche. The long term aim of Roche in China is to discover and optimise new molecules which would address the unmet medical needs of China and the world. How Roche capitalised on the growing pharmaceutical industry of China and realised its ambitions remained to be seen.

Pedagogical Objectives:

  • To analyse the pharmaceutical industry in China and its growing relevance in the global pharmaceutical industry
  • To undertake the SWOT analysis of Roche with regard to its ambitions in China
  • To discuss the growth strategies of Roche in China.

Keywords : Roche; China; Pharmaceuticals; Diagnostics; Research & Development Center;Iindustry structure; Patent laws; Intellectual Property; WTO, low cost Manufacturing; Traditional Medicine; Market potential; GMP; Demographics; Challenges; Growth Strategies Case Study; Counterfeited drugs; Guanxi; Joint Venture; Customer Relationship Management

Contents : 
About Roche
The pharmaceutical industry in China
Recent developments
R&D partnerships involving MNCs in China
New Drug approvals in China
Demographic trends
The position of China’s pharmaceutical industry in the world
Top 10 pharmaceutical companies in China

Recently Bought Case Studies

    Recently Bought Case Studies

    Executive Interviews

  • David ConklinDavid Conklin

    David Conklin, is a professor at the Richard Ivey School of Business
    Speaks on Government and Business
  • Lord Meghnad DesaiLord Meghnad Desai

    Lord Meghnad Desai, is an Indian-born British economist and Labor politician
    Speaks on Government and Business
  • Vijay GovindarajanVijay Govindarajan

    Vijay Govindarajan, is widely regarded as one of the world’s leading experts on strategy and innovation
    Speaks on Reverse Innovation
  • View All Executive Interviews»

Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501203, Telangana, INDIA.
Mob: +91- 9640901313,

©2020 - 25 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap